Patient Square Capital’s EyePoint EYPT Stock Holding History
Bought
Maintained
Sold
Other funds holding EYPT
Patient Square Capital's EYPT Position: Q3 2026 in Review
Patient Square Capital sold out of EyePoint (EYPT) in Q3 2026, closing a stake of 720,000 shares — an estimated $10.3M sold.
Patient Square Capital first reported a position in EYPT in Q3 2024 and held it in 8 quarters. The position peaked at $14.4M in Q3 2025. 190 funds tracked by Wall St. Rank hold EYPT as of Q3 2026.
- Patient Square Capital reported no remaining EyePoint position as of Q3 2026 after selling out during the quarter.
- Patient Square Capital sold 720,000 EyePoint shares in Q3 2026, an estimated $10.3M.
- Patient Square Capital first reported a position in EyePoint in Q3 2024 and held it in 8 quarters.
- Patient Square Capital's EyePoint position peaked at $14.4M in Q3 2025.
- 190 funds tracked by Wall St. Rank held EyePoint as of Q3 2026.
Based on Patient Square Capital's 13F filing for Q3 2026, filed 10 Nov 2026.